DFTX
#1289
Definium Therapeutics, Inc. - Common Shares
40.9 8 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.48%
Variación mensual
-8.89%
Variación en los últimos 6 meses
+144.51%
Cambio anual
+171.21%
Cierres anteriores
43.8 2
Open
40.9 8
Mínimo
40.9 8
Máximo
40.9 8
Volumen
196
Financials
- Market Capitalization 5.51 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14
Relación precio/flujo de caja
-33.21 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1276 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.49 USD | -1.42% | -2.02% | -4.87% | +49.90% | 5.59 B USD | ||
| 1279 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.72 USD | -2.78% | -1.52% | +18.91% | +13.18% | 5.58 B USD | ||
| 1348 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.11 USD | -2.09% | -1.32% | +10.10% | +12.35% | 5.02 B USD | ||
| 1399 |  DYN Dyne Therapeutics, Inc. - Common Stock | 25.07 USD | -3.91% | -4.06% | -2.83% | +7.09% | 4.68 B USD |